Improving Operating Profit Margin and Profitability
First written in FY2017. 3 of 13 entries say "Raised", first in FY2022. Latest entry: 2026-07-31.
The whole theme swung hardest in 2019: 14 of 100 companies on the "Worse" side.
16 other companies' latest entry also says "Softened".
- FY2026Profitability deteriorated despite higher revenueAnnual report
「Although we secured higher revenue, operating loss and ordinary loss were recorded because of the higher cost-of-sales ratio and increases in selling, general and administrative expenses, mainly research and development expenses.」
The record shows that, despite higher revenue, the Company posted an operating loss and an ordinary loss while pursuing improved profitability. - FY2025RaisedAnnual report
「By executing these initiatives, we have achieved ROE of at least 10%, a 10-year average growth rate (CAGR) of at least 5% for revenue, and operating income before research and development expenses of at least 10%. In addition, we define the five years of Beyond 80 as a period for growth investment and commit to our shareholders to raise PBR above 1x and ROE to at least 8%.」
In addition to the previously established targets of ROE of at least 8% and PBR of at least 1x, the Company has set long-term targets for ROE of at least 10% in 10 years, sales CAGR of at least 5%, and operating profit CAGR before deducting R&D expenses of at least 10%. - FY2024RaisedAnnual report
「We have designated ROE as our most important management indicator and are targeting ROE of at least 8% as our desired future state. … We are working to improve capital efficiency, defining our desired future state as a financial position with ROE of at least 8%, a PBR of at least 1x and policy-held shares accounting for no more than 10% of net assets.」
The target was raised from ROE of at least 5% to ROE of at least 8% as the desired future state, with PBR of at least 1x and policy-held shares of no more than 10% also added. - FY2022RaisedAnnual report
「For net income attributable to owners of the parent, we will set a target of maintaining ROE of at least 5%.」
A target of maintaining ROE of at least 5% was explicitly stated for return on equity. - FY2020Expansion of target metricsAnnual report
「These investments are essential for establishing our future earnings structure. In the process, our goal is ultimately to improve the operating margin and return on equity by pursuing efficiency from every perspective and improving profitability.」
In addition to the previous goal of improving the operating margin, improving return on equity was explicitly identified as a target metric. - FY2019RestatedAnnual report
「Although the continued rollout of these research and development and alliance investments may temporarily affect performance, they are essential investments for establishing our future earnings structure. In the process, our goal is ultimately to improve the operating margin by pursuing efficiency from every perspective and improving profitability.」
The goal of establishing an earnings structure supporting research and development and alliance investments and improving the operating margin through greater efficiency and profitability improvement was reaffirmed. - FY2018RestatedAnnual report
「Our goal is to improve the operating margin by pursuing efficiency from every perspective and improving profitability in order to establish an earnings structure that can continuously support these research and development and alliance investments.」
The goal of establishing an earnings structure supporting research and development and alliance investments and improving the operating margin was reaffirmed. - FY2017First statedAnnual report
「Our goal is to improve the operating margin by pursuing efficiency from every perspective and improving profitability in order to establish an earnings structure that can continuously support these research and development and alliance investments.」
A new goal was explicitly stated to improve the operating margin through the pursuit of efficiency and profitability improvement in order to establish an earnings structure supporting research and development and alliance investments.